Condition: Grief · Post Traumatic Stress Disorder · Suicidal Ideation · Sponsor: Oregon Research Behavioral Intervention Strategies, Inc.
The goal of this clinical trial is to learn if the Along With Me web-based intervention works to decrease posttraumatic stress symptoms and suicidal ideation among bereaved parents following pregnancy and early infant loss. It will also learn whether peer guides provide additional improvements on these outcomes. The main questions it aims to answer are: • Do people who receive Along With Me or Along With Me plus a Peer Guide compared to services as usual have lower posttraumatic stress symptoms and suicidal ideation than those who do not receive the intervention? Researchers will compare Along With Me and Along With Me plus a Peer Guide to services as usual (referrals made in the hospital setting) to see if Along With Me works to prevent and address posttraumatic stress symptoms and suicidal ideation. Participants will: * Receive access to a mobile app with approximately 10 therapeutic modules about how to manage grief and other symptoms. * Receive check-ins with a Peer Guide (in the Peer Guide condition only)
This description comes directly from the study's public registry record.
David R Smith, PhD · 541-484-2123 · david.smith@influentsin.com
Camille Cioffi, PhD · 541-484-2123 · camille.cioffi@influentsin.com
Always discuss trial participation with your own doctor first.
| Oregon Research Behavioral Intervention Strategies, Inc. | Eugene, Oregon, United States | Recruiting |
| Oregon Research Behavioral Strategies, Inc. | Springfield, Oregon, United States | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07011940